15 Judge Graham observed of s 6 of the Act that it provides an exclusive definition of the circumstances in which a person takes part in the manufacture of a prohibited drug. In his Honour's view the Crown case, taken at its highest, could not support a finding that the respondent took part in the manufacture of methylamphetamines because it could not be shown that he took or participated in any step in the process of that manufacture, within the meaning of s 6(a) of the Act.
16 The Crown contended that the acquisition and transportation of chemicals and equipment necessary for the manufacture of methylamphetamines was a step in the process of manufacture. The Crown also relied on the removal of the Sudafed tablets from their blister packs as a discrete step in the process of manufacture.
17 Judge Graham accepted that a step, being an intermediate stage in the process of manufacturing a prohibited drug, would fall within the terms of s 6(a). In this respect his Honour accepted that it would not be necessary, at the time of taking the intermediate step, for the person to have possession of (or access to) all of the equipment and all of the chemicals necessary to complete the process. The question his Honour identified was "whether the acquisition of the wherewithal and its transportation to another place amount to a step in the process of manufacture". His Honour considered that a distinction should be drawn between preparatory acts and acts which, in truth, represented steps in the process of manufacture. It followed that acts which were merely preparatory did not fall within the statutory prohibition.
18 In Judge Graham's view the acquisition and transportation of the chemicals amounted to no more than the respondent equipping himself with materials necessary to undertake the process of manufacture at a future time. In similar vein the removal of the Sudafed tablets from their blister packs could not be described as anything more than preparation for a future process of manufacture.
19 In submissions before this Court the Crown contended that Judge Graham erred in drawing the distinction between acts which are merely preparatory to the process of manufacture and steps in a process of manufacture.
20 In the Crown's submission the terms of s 6 are broad and encompass the acquisition and transportation of any materials to be used in the subsequent manufacture of prohibited drugs. In support of this submission the Crown relied on the observations of Gleeson CJ in R v Thomas (1993) 67 A Crim R 308 at 310:
"It is to be noted at the outset that the concept of taking a step in process of manufacture appears, in s 6 of the Act, in a context which manifests a legislative intention that is inconsistent with any narrow or pedantic approach to the description of activities connected with bringing prohibited drugs into existence, (b) and (c) of s 6 demonstrate that."